C9orf72 and cancer: As a proof of concept, we targeted loci in healthy donor DNA, including a highly variable hexanucleotide repeat in C9orf72, and four cancer-related genes with guide RNAs previously validated for PCR-free targeted sequencing (GSTP1, KRT19, GPX1, SLC12A4) [16].